SEC Comment Letter 0000000000-23-005834 to Arcellx, Inc. (ACLX) (CIK 0001786205) (ACLX)
Arcellx, Inc. (ACLX) (CIK 0001786205)
Date: June 2, 2023 · CIK: 0001786205 · Accession: 0000000000-23-005834
AI Filing Summary & Sentiment
File numbers found in text: 001-41259
Letter
United States securities and exchange commission logo June 2, 2023 Michelle Gilson Chief Financial Officer Arcellx, Inc. 25 West Watkins Mill Road, Suite A Gaithersburg, MD 20878 Re:Arcellx, Inc. Form 10-K for the fiscal year ended December 31, 2022 Filed March 29, 2023 File No. 001-41259 Dear Michelle Gilson: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
June 2, 2023
Michelle Gilson
Chief Financial Officer
Arcellx, Inc.
25 West Watkins Mill Road, Suite A
Gaithersburg, MD 20878
Re:Arcellx, Inc.
Form 10-K for the fiscal year ended December 31, 2022
Filed March 29, 2023
File No. 001-41259
Dear Michelle Gilson:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences